Support pre-clinical testing and pilot production for non-hormonal contraceptive ring
Elle, MD Biotechnologies Inc.
5 records totalling $664,848.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| Atlantic Canada Opportunities Agency | $350,000 | 2 records |
| National Research Council Canada | $314,848 | 3 records |
Records
Elle, MD Biotechnologies Inc.
$300,000.00
Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
REGI - Business Scale-Up and Productivity (BSP)
FY 2025-2026
Canada
Elle, MD Biotechnologies Inc.
$236,848.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
FY 2026-2027
Canada
Research activities to develop a novel Vaginal Contraceptive Device while managing toxicity and biocompatability requirements.
Elle, MD Biotechnologies Inc.
$75,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2025-2026
Canada
The Firm is researching non-hormonal contraceptive methods and developing a novel, monthly, self-administered vaginal ring that utilizes copper.
Elle, MD Biotechnologies Inc.
$50,000.00
Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique
REGI - Strategic Growth Initiative (SGI)
FY 2025-2026
Canada
Engage business development expertise to support capital raising and growth planning
Elle, MD Biotechnologies Inc.
$3,000.00
National Research Council Canada | Conseil national de recherches Canada
CanExport
FY 2026-2027
Canada
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...